Search results

A new platform dedicated to research in the humanities and social sciences (SHS) is being launched at UNamur. The aim? To offer SHS researchers methodological support tailored to their needs and strengthen SHS excellence at UNamur. This platform, SHS Impulse, will provide various services such as financial support for training, consultancy, access to resources, or co-financed software purchases.

A major breakthrough for the health of women on oral contraceptives has been achieved by researchers in Namur. Every year in Europe, more than 22,000 cases of venous thrombosis or embolism occur among contraceptive pill users. A team of researchers from the University of Namur, in collaboration with QUALIblood (spin-off), has conducted an important study, the results of which could transform prescribing recommendations..

Bringing a new drug to market, particularly when it is intended to treat a pediatric or orphan disease, is a journey fraught with pitfalls. The ERAMET project, coordinated by Professor Flora Musuamba Tshinanu, aims to overhaul the assessment procedures, so that regulatory agencies can take innovative technologies into account and thus make more informed choices.

On May 10, 2025, Vice-Rector Carine Michiels and Professor Anne-Catherine Heuskin handed over UNamur's cheque at the grand closing evening of Operation Télévie, which this year raised a record €13,351,977 for the Fonds National de la Recherche Scientifique. Télévie funds are used entirely to finance cancer research projects at universities in the Wallonia-Brussels Federation and the Grand Duchy of Luxembourg.

Researchers at the Universities of Namur (UNamur), Brussels (ULB) and Liège (ULiège) have just taken a key step towards understanding viral mechanisms. Their study, published in the international scientific journal PLOS Pathogens, focuses on a particular type of molecule produced by viruses, circular RNAs, and presents an innovative bioinformatics tool capable of better identifying them.

Hepatocellular carcinoma is the most common primary liver cancer. Unfortunately, this tumor still has a high mortality rate due to the lack of effective treatments for its most advanced or poorly localized forms. As part of a partnership with the CHU UCL Namur - site de Godinne and with the support of Roche Belgium, researchers in the Department of Biomedical Sciences are trying to understand why liver tumor cells are so resistant to treatment, and to identify therapeutic alternatives to better target them.

This is a significant honor for two members of the UNamur School of Medicine: Professor Charlotte Beaudart, who heads the "clinical research" track of the Master’s program in biomedical sciences, and Professor Jonathan Douxfils (School of Medicine, URPC – NARILIS) have just joined the College of Young Researchers of the Royal Academy of Medicine of Belgium.

A team of microbiology researchers from UNamur has just published in the journal Nature Communications. The work focuses on the Brucella bacterium that causes Brucellosis, a disease that infects livestock and can be transmitted to humans. This research aims to better understand the molecular mechanisms of the bacterium's growth in order to better combat it.

With its expertise in the field of geology and biodiversity conservation, the UNamur is one of the partners of the new Entre-Sambre-et-Meuse National Park designated by the Walloon Government. Alongside the other actors and promoters of the project, the UNamur will make its knowledge and experience available to enhance and preserve this exceptional natural heritage!

When a tumour develops in an organism, it is very common for the cancer cells to leave the tumour and move to another organ where they proliferate, creating what are known as metastases. This process is an important factor in mortality, as it means that the disease worsens. Hence the interest in better understanding what happens during this phenomenon. This is what the multidisciplinary team of Carine Michiels, researcher at the NARILIS Institute of UNamur, and Davide Bonifazi, researcher at the University of Vienna, did in the framework of the PACMAN research project financed by the FNRS. The results of this study are published in the journal Neoplasia.

In late November, the Mont-Saint-Guibert-based company Cellistic® donated equipment it no longer used to UNamur. By enabling the university to give this equipment a second life, Cellistic is making an important gesture in support of the development of university research.

Since September 2023, Marc Hennequart, Professor of Biochemistry and Cell Biology at UNamur, has been conducting groundbreaking research into pancreatic cancer. His team, based at the Faculty of Medicine and the Institut Narilis, studies the early stages of oncogenesis (the process of transforming a normal cell into a cancerous one) to better understand the metabolic changes behind this particularly aggressive cancer.